Anzeige
Mehr »
Donnerstag, 14.08.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40LMS | ISIN: US80303D3052 | Ticker-Symbol:
NASDAQ
13.08.25 | 21:59
39,770 US-Dollar
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SANUWAVE HEALTH INC Chart 1 Jahr
5-Tage-Chart
SANUWAVE HEALTH INC 5-Tage-Chart

Aktueller Chart SANUWAVE HEALTH Aktie

Chart vergleichen mit:

Firmenname, WKN, ISIN oder Aktien-Kürzel

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%
Chart-Typ:
Zeitraum:
 
SANUWAVE HEALTH INC-Investoren interessieren sich auch für diese Wertpapiere
Dividendenbekanntmachungen (23.06.2025) Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  AECON GROUP INC  CA00762V1094  0,19 CAD  0,12 EUR  ARROWMARK FINANCIAL CORP  US8617801043  0,45 USD  0,3905 EUR  ASSECO POLAND SA  PLSOFTB00016  3...
► Artikel lesen
IRIDEX Corporation: Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025MOUNTAIN VIEW, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq:IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and...
► Artikel lesen
IRIDEX Corporation: Iridex Reports Fourth Quarter and Full Year 2024 Financial ResultsMOUNTAIN VIEW, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and...
► Artikel lesen
IRIDEX Corporation: Iridex Comments on Recent Stock Price VolatilityMOUNTAIN VIEW, Calif., March 14, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices...
► Artikel lesen
Medexus Pharmaceuticals Inc.: Medexus Announces Fiscal Q1 2026 Results, Including Positive Results from US Launch of GRAFAPEX (treosulfan) for InjectionFiscal Q1 2026 net revenue of $24.6 million, net income of $0.5 million, operating income of $0.9 million, and Adjusted EBITDA* of $3.4 million$3.0 million of product-level net revenue from GRAFAPEX...
► Artikel lesen
Medexus Pharmaceuticals Inc.: Medexus Schedules First Fiscal Quarter 2026 Conference CallToronto, Ontario and Chicago, Illinois--(Newsfile Corp. - August 5, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Wednesday, August...
► Artikel lesen
Medexus Pharmaceuticals Inc.: GRAFAPEX (treosulfan) for Injection Receives CMS Approval of New Technology Add-On Payment (NTAP) for Eligible Cases in CMS's Fiscal Year 2026Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - August 5, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that the US Centers for Medicare & Medicaid Services...
► Artikel lesen